CITIUS ONCOLOGY, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Citius Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q2 2024.
  • Citius Oncology, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 4.31M shares, a 34.7% decline year-over-year.
  • Citius Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 6.6M shares, a 392% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 4.31M -2.29M -34.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 4.74M -1.86M -28.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 6.6M +5.26M +392% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 6.6M +5.1M +340% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 6.6M +5.1M +340% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 6.6M +4.88M +283% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 1.34M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 1.5M 0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 1.5M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-16
Q1 2022 1.73M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 1.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.